Antithrombotic Treatment after Carotid Stenting in Patients with Concomitant Atrial Fibrillation

References

1. 1.↵
   1. Kolominsky-Rabas PL,
   2. Weber M,
   3. Gefeller O, et al

   . Epidemiology of ischemic stroke subtypes according to TOAST criteria incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735–40 doi:10.1161/hs1201.100209 pmid:11739965

   Abstract/FREE Full Text
2. 2.↵
   1. Cole TS,
   2. Mezher AW,
   3. Catapano JS, et al

   . Nationwide trends in carotid endarterectomy and carotid artery stenting in the Post-CREST era. Stroke 2020;51:579–87 doi:10.1161/STROKEAHA.119.027388 pmid:31847750

   CrossRefPubMed
3. 3.↵
   1. Sussman ES,
   2. Jin M,
   3. Pendharkar AV, et al

   . Dual antiplatelet therapy after carotid artery stenting: trends and outcomes in a large national database. J Neurointerv Surg 2021;13:8–13 doi:10.1136/neurintsurg-2020-016008 pmid:32414894

   Abstract/FREE Full Text
4. 4.↵
   1. Noubiap JJ,
   2. Agbaedeng TA,
   3. Ndoadoumgue AL, et al

   . Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa. Am J Cardiol 2021;138:72–79 doi:10.1016/j.amjcard.2020.10.017 pmid:33065087

   CrossRefPubMed
5. 5.↵
   1. Lehtola H,
   2. Airaksinen EJ,
   3. Hartikainen P, et al

   . Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk. Eur J Neurol 2017;24:719–25 doi:10.1111/ene.13280 pmid:28317289

   CrossRefPubMed
6. 6.↵
   1. Lopes RD,
   2. Vora AN,
   3. Massaro T, et al

   . Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. N Engl J Med 2019;380:1509–24 doi:10.1056/NEJMoa1817083 pmid:30883055

   CrossRefPubMed
7. 7.↵
   1. Gibson CM,
   2. Mehran R,
   3. Bode C, et al

   . Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med 2016;375:2423–34 doi:10.1056/NEJMoa1611594 pmid:27959713

   CrossRefPubMed
8. 8.↵
   1. Cannon CP,
   2. Bhatt DL,
   3. Oldgren J, et al

   . Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 2017;377:1513–24 doi:10.1056/NEJMoa1708454 pmid:28844193

   CrossRefPubMed
9. 9.↵
   1. Schulman S,
   2. Anger SU,
   3. Bergqvist D, et al

   . Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010;8:202–04 doi:10.1111/j.1538-7836.2009.03678.x pmid:19878532

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Ruff CT,
    2. Giugliano RP,
    3. Braunwald E, et al

    . Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014;383:955–62 doi:10.1016/S0140-6736(13)62343-0 pmid:24315724

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Nii K,
    2. Takemura Y,
    3. Inoue R, et al

    . Safety of direct oral anticoagulant - and antiplatelet therapy in patients with atrial fibrillation treated by carotid artery stenting. J Stroke Cerebrovasc Dis 2020;29:10–15 doi:10.1016/j.jstrokecerebrovasdis.2020.104899 pmid:32402723

    CrossRefPubMed